SCHEMBL8537606

SCHEMBL8537606

O=C(O)CN1CCN(CC(=O)O)CCN(CC(O)CCCCCCCCCOc2ccc(OCc3ccccc3)cc2)CCN(CC(=O)O)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.56
POLB P06746 1/20 0.56
RAB9A P51151 5/20 0.54
TSHR P16473 1/20 0.54
HSD17B10 Q99714 1/20 0.54
ALDH1A1 P00352 6/20 0.53
KDM4E B2RXH2 4/20 0.53
NPC1 O15118 3/20 0.53
HTT P42858 3/20 0.53
NPSR1 Q6W5P4 1/20 0.53
GAA P10253 1/20 0.52
KMT2A Q03164 1/20 0.52
NPY1R P25929 1/20 0.52
SMN1; SMN2 Q16637 4/20 0.51
LMNA P02545 2/20 0.47
PRMT5 O14744 1/20 0.47
WDR77 Q9BQA1 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8537598 0.89 KCNH2 (0.44) L3MBTL1POLBTSHRALDH1A1KDM4E
SCHEMBL8482730 0.88 TSHR (0.49) L3MBTL1POLBRAB9ATSHRALDH1A1
SCHEMBL9315964 0.80 ITGB3 (0.47) L3MBTL1POLBRAB9ATSHRHSD17B10
SCHEMBL8537608 0.80 L3MBTL1 (0.54) L3MBTL1POLBRAB9ATSHRHSD17B10
SCHEMBL8478663 0.80 EGFR (0.49) L3MBTL1POLBRAB9AALDH1A1KDM4E
SCHEMBL8482606 0.80 L3MBTL1 (0.43) L3MBTL1POLBRAB9ATSHRHSD17B10
SCHEMBL8478273 0.79 TSHR (0.58) L3MBTL1POLBRAB9ATSHRHSD17B10
SCHEMBL8478625 0.79 EGFR (0.45) L3MBTL1POLBRAB9ATSHRHSD17B10
SCHEMBL8478670 0.75 TSHR (0.70) L3MBTL1POLBRAB9ATSHRHSD17B10
SCHEMBL8482310 0.75 ALDH1A1 (0.45) L3MBTL1POLBHSD17B10ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0485045-B1 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AG (DE) 1998-12-30 EP disclosed
US-5277895-A Nuclear magnetic resonance SCHERING AKTIENGESELLSCHAFT (DE) 1994-01-11 US disclosed
EP-0485045-A2 Mono-N-substituted 1,4,7,10-Tetraazacyclododecan-derivatives, process for their preparation and pharmaceutical agent containing them SCHERING AKTIENGESELLSCHAFT (DE) 1992-05-13 EP disclosed